For instance, in a mouse model of S. japonicum-induced liver fibrosis, the PPAR-γ agonist rosiglitazone was able to reduce liver fibrosis and extracellular matrix (ECM) deposition, which was attributed to decreased inflammatory signaling (175). The gene discussed is PPARG; the disease is Hepatic fibrosis.